Human Blood Specimens
ABS Bio provides high-quality human blood and blood-derived specimens to support drug discovery, translational research, biomarker development, and clinical assay validation.
Through a global network of clinical collection sites, ABS Bio delivers normal and diseased specimens with rapid turnaround times, customizable collection criteria, and comprehensive patient annotation to support a wide range of research applications.
Capabilities
- Access normal and diseased blood specimens through remnant and prospective collection programs.
- Customize collections using study-specific inclusion and exclusion criteria, including age, sex, ethnicity, disease characteristics, smoking status, and other patient factors.
- Rapid collection and overnight shipping workflows help preserve sample quality and accelerate research timelines.
- Comprehensive patient annotation may include demographics, medical history, treatment information, laboratory results, molecular testing data, biomarker profiles, and clinical outcomes.
- Flexible collection protocols support liquid biopsy development, biomarker discovery, translational research, clinical assay validation, and other fit-for-purpose applications.
- All specimens are collected under IRB-approved protocols with strict quality standards, informed consent, and patient confidentiality protections.

Plasma
ABS Bio provides high-quality human plasma specimens to support biomarker discovery, liquid biopsy development, translational research, and drug development programs. Available through both inventory and prospective collections, plasma specimens are processed to preserve sample integrity and support highly sensitive downstream analytical applications.
Key Features
- Access normal and diseased plasma specimens through inventory and prospective collection programs.
- Double-spun plasma processing minimizes residual cellular contamination for high-sensitivity applications, including cfDNA, ctDNA, extracellular vesicle, RNA, and miRNA analysis.
- Available in a variety of collection formats and volumes to support biomarker discovery, liquid biopsy development, pharmacokinetic (PK), and pharmacodynamic (PD) studies.
- Comprehensive patient annotation may include demographics, medical history, treatment information, laboratory results, molecular testing data, biomarker profiles, and clinical outcomes.
- Rapid collection and processing workflows help preserve sample integrity and support advanced molecular and analytical assays.
- All specimens are collected under IRB-approved protocols with strict quality standards, informed consent, and patient confidentiality protections.
Serum
ABS Bio provides high-quality human serum specimens to support immunology, biomarker discovery, assay development, cell culture, and translational research. Available through both inventory and prospective collection programs, ABS Bio offers normal and diseased serum samples processed to deliver consistent quality, reliable performance, and comprehensive patient annotation across a broad range of downstream research applications.
Key Features
- Access normal and diseased serum specimens through a worldwide network of clinical collection sites, with both inventory and prospective collection options available.
- Widely used for antibody detection, serology, vaccine research, autoimmune disease profiling, and immunological assay development.
- Supports biomarker discovery, diagnostic development, cell culture applications, and translational research across a broad range of therapeutic areas.
- Comprehensive patient annotation may include demographics, medical history, treatment information, laboratory results, molecular testing data, biomarker profiles, and clinical outcomes.
- Rapid collection and processing workflows help maintain sample quality and consistency across research programs and assay platforms.
- All specimens are collected under IRB-approved protocols with strict quality standards, informed consent, and patient confidentiality protections.


PBMCs
ABS Bio provides high-quality human PBMCs (Peripheral Blood Mononuclear Cells) to support immunology research, cell and gene therapy development, biomarker discovery, and translational research. Available from normal and diseased donors, PBMCs are delivered with high viability, comprehensive patient annotation, and flexible collection options to support a broad range of research and therapeutic development programs.
PBMCs are widely used in immuno-oncology, autoimmune disease research, infectious disease studies, and advanced cell-based assays.
Applications and Capabilities
- Access normal and diseased PBMCs through inventory and prospective collection programs.
- Supports immuno-oncology research, cell and gene therapy development, immune monitoring, biomarker discovery, infectious disease research, and autoimmune disease studies.
- High-viability PBMCs support flow cytometry, functional immune assays, cell culture, cytokine profiling, and molecular analysis.
- Comprehensive patient annotation includes demographics, medical history, treatment information, laboratory results, molecular testing data, biomarker profiles, and clinical outcomes.
- Custom collection and processing protocols can be tailored to study-specific inclusion and exclusion criteria, disease-specific requirements, and translational research objectives.
- All specimens are collected under IRB-approved protocols with strict quality standards, informed consent, and patient confidentiality protections.
